What is Cagrilintide?

Cagrilintide is a long-acting amylin analogue. Amylin is a hormone released with insulin that:

Suppresses appetite

Slows gastric emptying

Reduces cravings and food noise

Improves portion control

It’s especially powerful for appetite control, and often stacked with GLP-1s (Semaglutide, Tirzepatide, Retatrutide).

Key Benefits

🔥 Strong appetite suppression

🍽️ Faster satiety (feel full quicker)

🧠 Reduces emotional & binge eating

⚖️ Helps break weight-loss plateaus

💉 Works well even at low doses

Common Side Effects

Usually dose-dependent:

Mild nausea (most common)

Full / heavy stomach feeling

Occasional reflux

Fatigue in the first 1–2 weeks

👉 Starting low and titrating slowly minimizes this.

Cagrilintide Protocol (Solo Use)

Injection: Subcutaneous (belly or thigh)

Frequency: Once weekly

Beginner / Conservative

Week 1–2: 0.25 mg weekly

Week 3–4: 0.5 mg weekly

Standard / Effective Range

Week 5+: 0.75 – 1.25 mg weekly

Most people find 0.5–1 mg more than enough.

Cagrilintide + GLP-1 Stack (Very Popular)

This combo is where Cagrilintide really shines 👌

Example:

Cagrilintide: 0.25–0.5 mg once weekly

Semaglutide / Tirzepatide: low–moderate dose

➡️ Cagrilintide controls appetite

➡️ GLP-1 improves glucose control & fat loss

This allows lower GLP-1 doses with better results and fewer side effects.

Storage

❄️ Refrigerate 2–8°C

Do not freeze

Protect from light

Who It’s Best For

✔️ People struggling with hunger/cravings

✔️ Emotional or binge eaters

✔️ Weight-loss plateaus

✔️ Those who can’t tolerate high GLP-1 doses